Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Oncology

Background:

• Targeted contrast agent detection is hindered by unbound agent background signals.
• Perfluorocarbon nanoparticles offer potential for targeted imaging.
• Angiogenesis in tumors presents a target for diagnostic and therapeutic strategies.

Purpose of the Study:

• To evaluate the efficacy of Fluorine-19 diffusion-weighted MR spectroscopy (DWS) for in vivo detection of angiogenesis-targeted perfluorocarbon nanoparticles.
• To differentiate between bound and unbound nanoparticles based on diffusion characteristics.
• To assess nanoparticle binding in a preclinical model of squamous cell carcinoma.

Main Methods:

• Utilized transgenic K14-HPV16 mice with epidermal squamous carcinomas and nontransgenic controls.
• Administered alpha(v)beta(3)-integrin targeted perfluorocarbon nanoparticles.
• Performed in vivo (19)F DWS on mouse ears at 11.74 Tesla with varying b-values (0-16,000 s/mm(2)).
• Analyzed signal decay patterns and estimated apparent diffusion coefficients (ADCs).

Main Results:

• (19)F signal decayed at low b-values in both groups, indicating background suppression.
• (19)F signal persisted at high b-values in tumor-bearing mice, signifying bound nanoparticles.
• Signal decayed completely in control mice at high b-values, indicating unbound, mobile nanoparticles.
• Estimated ADCs were significantly different: 33.1 ± 12.9 µm(2)/s in K14-HPV16 mice vs. 19563 ± 5858 µm(2)/s in controls (p < 0.01).

Conclusions:

• In vivo (19)F DWS effectively distinguishes bound from unbound perfluorocarbon nanoparticles.
• The technique enables specific detection of nanoparticle binding to tumor angiogenesis.
• (19)F DWS holds promise for real-time monitoring of targeted nanoparticle delivery and accumulation in vivo.